Cerenome appoints director Ron Andrews as chief business officer
CNSY•Cerenome appointed Ron Andrews as chief business officer, a newly created role focused on expanding adoption of its CNSide diagnostics platform and developing strategic partnerships.
1. New leadership role
Andrews will focus on expanding adoption of the CNSide diagnostics platform and developing strategic partnerships. He brings more than 35 years of diagnostics leadership experience, including CEO roles at Clarient and Oncocyte.
